Literature DB >> 2302179

Characterization of the active site of human multicatalytic proteinase.

R W Mason1.   

Abstract

The activity of multicatalytic proteinase against synthetic substrates and the kinetics of its inhibition by a range of class-specific inhibitors have been investigated. The enzyme was found to have a broader pH activity profile than previously noted, being active against succinyl-Ala-Ala-Phe-7-amino-4-methylcoumarin optimally at pH 4.5 and against benzyloxycarbonyl-Gly-Gly-Arg-7-amino-4-methylcoumarin optimally at pH 10.5. Neither activity was inhibited by the class-specific inhibitors 1,10-phenanthroline, EDTA, pepstatin, di-isopropyl fluorophosphate, peptidyl chloromethanes, peptidyl diazomethanes or L-3-carboxy-2,3-trans-epoxypropionyl-leucylamido-(4-guanidin o)butane (E-64), indicating that the enzyme is not a typical metallo-, aspartic, serine or cysteine proteinase. Inhibition by HgCl2, iodoacetamide and N-ethylmaleimide suggests that free thiols are necessary for the enzyme to maintain activity, but that these thiols are not particularly reactive as is the case for cysteine proteinases of the papain superfamily. The peptidyl aldehydes chymostatin and leupeptin were found to be reversible inhibitors of multicatalytic proteinase. Chymostatin inhibited activity against succinyl-Ala-Ala-Phe-7-amino-4-methylcoumarin at pH 4.5 (Ki 160 +/- 22 microM) whereas leupeptin (200 microM) was not inhibitory. Inhibition of activity against benzyloxycarbonyl-Gly-Gly-Arg-7-amino-4-methylcoumarin by these compounds was more complex, in that they behaved as slow tight-binding inhibitors. kon values were determined to be 12 +/- 2 M-1.s-1 and 1290 +/- 125 M-1.s-1 for chymostatin and leupeptin, respectively. The upper limit for Ki values for these two inhibitors was estimated as 5 +/- 1.5 microM and 25 +/- 5 nM, respectively. The different inhibition characteristics for each substrate were also apparent at an intermediate pH of 8.5, showing that the two activities are distinct. Dichloroisocoumarin, a mechanism-based inhibitor of serine proteinases, did inhibit activity against succinyl-Ala-Ala-Phe-7-amino-4-methylcoumarin with a rate constant of 250 M-1.s-1, suggesting that multicatalytic proteinase is an atypical serine proteinase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302179      PMCID: PMC1136909          DOI: 10.1042/bj2650479

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Mapping the active site of papain with the aid of peptide substrates and inhibitors.

Authors:  A Berger; I Schechter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1970-02-12       Impact factor: 6.237

2.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

Authors:  P J Henderson
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

3.  Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex.

Authors:  S Wilk; M Orlowski
Journal:  J Neurochem       Date:  1983-03       Impact factor: 5.372

Review 4.  Low-molecular-weight enzyme inhibitors of microbial origin.

Authors:  H Umezawa
Journal:  Annu Rev Microbiol       Date:  1982       Impact factor: 15.500

5.  Negatively charged reactants as probes in the study of the essential mercaptide-imidazolium ion-pair of thiolenzymes.

Authors:  P Halász; L Polgár
Journal:  Eur J Biochem       Date:  1977-10-03

6.  Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor.

Authors:  J W Harper; K Hemmi; J C Powers
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

7.  Purification and characterization of a multicatalytic high-molecular-mass proteinase from rat skeletal muscle.

Authors:  B Dahlmann; L Kuehn; M Rutschmann; H Reinauer
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

8.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

9.  The slow, tight-binding inhibition of cathepsin B by leupeptin. A hysteretic effect.

Authors:  A Baici; M Gyger-Marazzi
Journal:  Eur J Biochem       Date:  1982-12

10.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

Authors:  W X Tian; C L Tsou
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

View more
  5 in total

Review 1.  Proteasomes: multicatalytic proteinase complexes.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

2.  Changes in intracellular localization of proteasomes in immortalized ovarian granulosa cells during mitosis associated with a role in cell cycle control.

Authors:  A Amsterdam; F Pitzer; W Baumeister
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

3.  Synthetic analogues of chymostatin. Inhibition of chymotrypsin and Streptomyces griseus proteinase A.

Authors:  N P Tomkinson; I J Galpin; R J Beynon
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

4.  Reaction of proteasomes with peptidylchloromethanes and peptidyldiazomethanes.

Authors:  P J Savory; H Djaballah; H Angliker; E Shaw; A J Rivett
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

5.  Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases.

Authors:  V Ustrell; G Pratt; M Rechsteiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.